Salmovac 440 Lyophilisate for use in drinking water
Salmovac 440 Lyophilisate for use in drinking water
Authorised
- Salmonella enterica, subsp. enterica, serovar Enteritidis, strain 441/014, Live
Product identification
Medicine name:
Salmovac 440 Lyophilisate for use in drinking water
CEVAC SALMOVAC, lüofilisaat joogivees manustamiseks
Active substance:
- Salmonella enterica, subsp. enterica, serovar Enteritidis, strain 441/014, Live
Target species:
-
Chicken
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Salmonella enterica, subsp. enterica, serovar Enteritidis, strain 441/014, Live800000000.00Colony forming unit1.00Dose
Pharmaceutical form:
-
Lyophilisate for use in drinking water
Withdrawal period by route of administration:
-
In drinking water use
-
Chicken
-
Egg3week3 weeks after third vaccination
-
Meat and offal6week6 weeks from last vaccination
-
Egg6week6 weeks after second vaccination
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AE01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- (ID4): 1 Box with 1 Vial (Glass) with 1000 vaccine doses (1000 vaccine doses)
- (ID3): 1 Box with 12 Vials (Glass) with 5000 vaccine doses (60000 vaccine doses)
- (ID2): 1 Box with 1 Vial (Glass) with 5000 vaccine doses (5000 vaccine doses)
- (ID1): 1 Box with 10 Vials(Glass) with 1000 vaccine doses (10000 vaccine doses)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- IDT Biologika GmbH
- Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 2322
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0208/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
France
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 2/03/2022
Estonian (PDF)
Published on: 22/03/2024
How useful was this page?: